A Role of Hypothalamic Dysfunction in Alcoholic Liver Disease

下丘脑功能障碍在酒精性肝病中的作用

基本信息

项目摘要

Insulin resistance is an important risk factor for alcoholic liver disease (ALD). Vice versa, heavy alcohol consumption induces insulin resistance that is associated with progression of hepatic fibrosis in non-alcoholic fatty liver disease (NAFLD). Insulin is the key hormone that regulates lipid and glucose metabolism; it is also an important regulator of inflammation. Thus, hepatic insulin action is likely a key player in the pathogenesis of ALD, yet the mechanisms through which impaired insulin action predisposes to ALD remain poorly understood. We and others have previously demonstrated that insulin signaling within the mediobasal hypothalamus (MBH) controls hepatic glucose production (hGP), very low density lipoprotein (VLDL) secretion, white adipose tissue (WAT) lipolysis and innate immunity through the autonomic nervous system. Based on our pilot data that demonstrate that in a rat model for binge drinking, i.e. short term alcohol consumption impairs glucose tolerance and induces insulin resistance that is due to impaired hepatic insulin action. Binge drinking markedly impairs hypothalamic insulin action, defined as the ability of hypothalamic insulin to suppress hGP and adipose tissue lipolysis. Thus, the major hypothesis proposed in this proposal is that some of the metabolic and innate immunity defects induced by alcohol are caused through brain effects disrupting autonomic control of both metabolism and innate immunity. In support ofthis novel paradigm we find that a central cause ofthe impaired hypothalamic insulin action is decreased insulin signaling in the hypothalamus likely due to increased inflammation, ER stress and expression of protein tyrosine phosphatase l b (PTPIb), a negative regulator of insulin signaling. Here we propose to delineate the mechanisms through which chronic alcohol consumption impairs insulin action, disrupts hepatic carbohydrate, amino acid and lipid metabolism and generates a pro-inflammatory environment within the liver that predisposes to ALD.
胰岛素抵抗是酒精性肝病(ALD)的重要危险因素。反之亦然,重度酒精 消费会诱导胰岛素抵抗,这与肝纤维化的进展有关 非酒精性脂肪肝(NAFLD)。胰岛素是调节脂质和葡萄糖的关键激素 代谢;它也是炎症的重要调节剂。因此,肝脏胰岛素作用可能是关键 酒精性肝病 (ALD) 发病机制中的一个重要因素,但胰岛素作用受损导致的机制 对 ALD 的了解仍知之甚少。我们和其他人之前已经证明,胰岛素信号传导 下丘脑内侧基底节 (MBH) 控制肝葡萄糖生成 (hGP),密度极低 脂蛋白(VLDL)分泌、白色脂肪组织(WAT)脂肪分解和先天免疫通过 自主神经系统。根据我们的试点数据表明,在酗酒的大鼠模型中, 即短期饮酒会损害葡萄糖耐量并诱发胰岛素抵抗,这是由于 肝脏胰岛素作用受损。酗酒会明显损害下丘脑胰岛素的作用,定义为 下丘脑胰岛素抑制 hGP 和脂肪组织脂解的能力。因此,主要假设 该提案提出的是,酒精引起的一些代谢和先天免疫缺陷是 由大脑影响破坏新陈代谢和先天免疫的自主控制引起。在 为了支持这一新范式,我们发现下丘脑胰岛素作用受损的一个主要原因是 下丘脑的胰岛素信号减弱可能是由于炎症增加、内质网应激和 蛋白酪氨酸磷酸酶 l b (PTPIb) 的表达,PTPIb 是胰岛素信号传导的负调节因子。在这里我们 提议描述长期饮酒损害胰岛素作用的机制, 扰乱肝脏碳水化合物、氨基酸和脂质代谢并产生促炎物质 肝脏内的环境容易导致 ALD。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

CHRISTOPH BUETTNER其他文献

CHRISTOPH BUETTNER的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('CHRISTOPH BUETTNER', 18)}}的其他基金

Role of CREG1 in metabolic homeostasis
CREG1 在代谢稳态中的作用
  • 批准号:
    10608346
  • 财政年份:
    2023
  • 资助金额:
    $ 5.56万
  • 项目类别:
Light, metabolic syndrome and Alzheimer's disease: a non-pharmacological approach
光、代谢综合征和阿尔茨海默病:非药物方法
  • 批准号:
    10357437
  • 财政年份:
    2021
  • 资助金额:
    $ 5.56万
  • 项目类别:
Light, metabolic syndrome and Alzheimer's disease: a non-pharmacological approach
光、代谢综合征和阿尔茨海默病:非药物方法
  • 批准号:
    10442504
  • 财政年份:
    2021
  • 资助金额:
    $ 5.56万
  • 项目类别:
Neural mechanisms for VGF regulation of energy balance
VGF 调节能量平衡的神经机制
  • 批准号:
    10197299
  • 财政年份:
    2018
  • 资助金额:
    $ 5.56万
  • 项目类别:
Light, metabolic syndrome and Alzheimer’s disease: a non-pharmacological approach
光、代谢综合征和阿尔茨海默病:非药物方法
  • 批准号:
    9927956
  • 财政年份:
    2018
  • 资助金额:
    $ 5.56万
  • 项目类别:
Neural mechanisms for VGF regulation of energy balance
VGF 调节能量平衡的神经机制
  • 批准号:
    9616382
  • 财政年份:
    2018
  • 资助金额:
    $ 5.56万
  • 项目类别:
Neural mechanisms for VGF regulation of energy balance
VGF 调节能量平衡的神经机制
  • 批准号:
    10208870
  • 财政年份:
    2018
  • 资助金额:
    $ 5.56万
  • 项目类别:
A Role of Hypothalamic Dysfunction in Alcoholic Liver Disease
下丘脑功能障碍在酒精性肝病中的作用
  • 批准号:
    9530801
  • 财政年份:
    2017
  • 资助金额:
    $ 5.56万
  • 项目类别:
A Role of Hypothalamic Dysfunction in Alcoholic Liver Disease
下丘脑功能障碍在酒精性肝病中的作用
  • 批准号:
    8785952
  • 财政年份:
    2014
  • 资助金额:
    $ 5.56万
  • 项目类别:
PROTEOMIC STUDY OF HEPATIC METABOLISM REGULATED BY HYPOTHALAMIC PATHWAYS
下丘脑通路调控的肝脏代谢的蛋白质组学研究
  • 批准号:
    8365471
  • 财政年份:
    2011
  • 资助金额:
    $ 5.56万
  • 项目类别:

相似海外基金

Deciphering the role of adipose tissue in common metabolic disease via adipose tissue proteomics
通过脂肪组织蛋白质组学解读脂肪组织在常见代谢疾病中的作用
  • 批准号:
    MR/Y013891/1
  • 财政年份:
    2024
  • 资助金额:
    $ 5.56万
  • 项目类别:
    Research Grant
ESTABLISHING THE ROLE OF ADIPOSE TISSUE INFLAMMATION IN THE REGULATION OF MUSCLE MASS IN OLDER PEOPLE
确定脂肪组织炎症在老年人肌肉质量调节中的作用
  • 批准号:
    BB/Y006542/1
  • 财政年份:
    2024
  • 资助金额:
    $ 5.56万
  • 项目类别:
    Research Grant
Activation of human brown adipose tissue using food ingredients that enhance the bioavailability of nitric oxide
使用增强一氧化氮生物利用度的食品成分激活人体棕色脂肪组织
  • 批准号:
    23H03323
  • 财政年份:
    2023
  • 资助金额:
    $ 5.56万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Development of new lung regeneration therapies by elucidating the lung regeneration mechanism of adipose tissue-derived stem cells
通过阐明脂肪组织干细胞的肺再生机制开发新的肺再生疗法
  • 批准号:
    23K08293
  • 财政年份:
    2023
  • 资助金额:
    $ 5.56万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Canadian Alliance of Healthy Hearts and Minds: Dissecting the Pathways Linking Ectopic Adipose Tissue to Cognitive Dysfunction
加拿大健康心灵联盟:剖析异位脂肪组织与认知功能障碍之间的联系途径
  • 批准号:
    479570
  • 财政年份:
    2023
  • 资助金额:
    $ 5.56万
  • 项目类别:
    Operating Grants
Determinants of Longitudinal Progression of Adipose Tissue Inflammation in Individuals at High-Risk for Type 2 Diabetes: Novel Insights from Metabolomic Profiling
2 型糖尿病高危个体脂肪组织炎症纵向进展的决定因素:代谢组学分析的新见解
  • 批准号:
    488898
  • 财政年份:
    2023
  • 资助金额:
    $ 5.56万
  • 项目类别:
    Operating Grants
A study on the role of brown adipose tissue in the development and maintenance of skeletal muscles
棕色脂肪组织在骨骼肌发育和维持中作用的研究
  • 批准号:
    23K19922
  • 财政年份:
    2023
  • 资助金额:
    $ 5.56万
  • 项目类别:
    Grant-in-Aid for Research Activity Start-up
A mechanism of lipid accumulation in brown adipose tissue
棕色脂肪组织中脂质积累的机制
  • 批准号:
    10605981
  • 财政年份:
    2023
  • 资助金额:
    $ 5.56万
  • 项目类别:
Obesity and Childhood Asthma: The Role of Adipose Tissue
肥胖和儿童哮喘:脂肪组织的作用
  • 批准号:
    10813753
  • 财政年份:
    2023
  • 资助金额:
    $ 5.56万
  • 项目类别:
Estrogen Signaling in the Ventromedial Hypothalamus Modulates Adipose Tissue Metabolic Adaptation
下丘脑腹内侧区的雌激素信号调节脂肪组织代谢适应
  • 批准号:
    10604611
  • 财政年份:
    2023
  • 资助金额:
    $ 5.56万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了